Abstract: A therapeutic material active against SARS-COV 2 and other microbial pathogens and method of administering the same.

Abstract: Method and composition for treating or preventing a respiratory illness. The method includes administering at least one dose of a pharmaceutically acceptable fluid having a pH less than 3.0 into contact with at least one region of the respiratory tract present in a patient in need thereof. Respiratory illness that can be treated include COVID-19.

Abstract: An apparatus for treating a stream of contaminated water having an elevated concentration of at least one of light metals, heavy metals, sulfates that includes at least one process fluid inlet communicating with a process conduit; at least one electrode reaction vessel in fluid communication with the process conduit, the reaction vessel having an interior chamber and at least one electrode positioned in the reaction chamber, the electrode powered by a alternating current source; and at least one magnetic field reaction vessel in fluid communication with the process conduit, the magnetic field reaction vessel having an outwardly oriented surface and an opposed inwardly oriented surface, the magnetic field reaction vessel having at least one magnet in contact with the inwardly oriented surface of the magnetic field reaction vessel.

Abstract: A composition comprising: at least one compound of the chemical structure: [ H x ? O ( x - 1 ) 2 ] ? Z y wherein x is and odd integer ?3; y is an integer between 1 and 20; and Z is one of a monoatomic ion from Groups 14 through 17 having a charge value between ?1 and ?3 or a polyatomic ion having a charge between ?1 and ?3; or Z?—Hx?Ox?-y? wherein x? is and integer greater than 3 y? is an integer less than x?; and Z? is one of a monoatomic cation, a polyatomic ion or a cationic complex; and at least one of a humectant emollient or carrier.

Abstract: A composition comprising: at least one compound of the chemical structure: ? H x ? O ( x - 1 ) 2 ? ? Z y wherein x is an odd integer ?3; y is an integer between 1 and 20; and Z is one of a monoatomic ion from Groups 14 through 17 having a charge value between ?1 and ?3 or a polyatomic ion having a charge between ?1 and ?3; or Z?—Hx?Ox?-y? wherein x? is an integer greater than 3 y? is an integer less than x?; and Z? is one of a monoatomic cation, a polyatomic ion or a cationic complex; and at least one of a humectant emollient or carrier.

Abstract: Method and composition for treating or preventing a respiratory illness. The method includes administering at least one dose of a pharmaceutically acceptable fluid having a pH less than 3.0 into contact with at least one region of the respiratory tract present in a patient in need thereof. Respiratory illness that can be treated include COVID-19.

Abstract: Method and composition for treating or preventing a respiratory illness. The method includes administering at least one dose of a pharmaceutically acceptable fluid having a pH less than 3.0 into contact with at least one region of the respiratory tract present in a patient in need thereof. Respiratory illness that can be treated include COVID-19.

Abstract: A pharmaceutically acceptable therapeutic inhalation fluid that is composed of a fluid carrier and a pharmaceutically acceptable acid formulation present in the fluid carrier in an amount sufficient to provide a solution pH between 1.5 and 2.5, the pharmaceutically acceptable acid formulation having anti-bacterial, and/or anti-viral, and/or anti-fungal activity and at least one antimicrobial peptide.

Abstract: A composition composed of: at least one compound of the chemical structure: ? H x ? O ( x - 1 ) 2 ? ? Z y wherein x is and odd integer ?3; y is an integer between 1 and 20; and Z is one of a monoatomic ion from Groups 14 through 17 having a charge value between ?1 and ?3 or a polyatomic ion having a charge between ?1 and ?3; or Z?—Hx?Ox??y? wherein x? is and integer greater than 3 y? is an integer less than x?; and Z? is one of a monoatomic cation, a polyatomic ion or a cationic complex; and at least one of a humectant emollient or carrier.

Abstract: Method and composition for treating or preventing a respiratory illness. The method includes administering at least one dose of a pharmaceutically acceptable fluid having a pH less than 3.0 into contact with at least one region of the respiratory tract present in a patient in need thereof. Respiratory illness that can be treated include COVID-19.

Abstract: A composition of matter having the following chemical structure: [ H x ? O ( x - 1 ) 2 ] ? Z y wherein x is and odd integer ?3; y is an integer between 1 and 20; and Z is one of a monoatomic ion from Groups 14 through 17 having a charge value between ?1 and ?3 or a polyatomic ion having a charge between ?1 and ?3.

Abstract: A cleaning wipe that is composed of a cleaning substrate and a cleaning composition that includes water and cleaning composition integrated therein. The cleaning composition comprises water and a liquid material component having between 0.5 and 2.0 M free hydrogen and between 100 ppm and 800 ppm calcium, the liquid material present in an amount capable of yielding a solution pH of 6.0 or below when present in the aqueous disinfectant composition together with a solubilizer present in an amount between 0 vol % and 5 vol %.

Abstract: A composition comprising: at least one compound of the chemical structure: ? H x ? O ( x - 1 ) 2 ? ? Z y wherein x is and odd integer ?3; y is an integer between 1 and 20; and Z is one of a monoatomic ion from Groups 14 through 17 having a charge value between ?1 and ?3 or a polyatomic ion having a charge between ?1 and ?3; or Z?—Hx?Ox??y? wherein x? is and integer greater than 3 y? is an integer less than x?; and Z? is one of a monoatomic cation, a polyatomic ion or a cationic complex; and at least one of a humectant emollient or carrier.

Abstract: A composition of matter having the following chemical structure: [ H x ? O ( x - 1 ) 2 ] ? Z y wherein x is and odd integer ?3; y is an integer between 1 and 20; and Z is one of a monoatomic ion from Groups 14 through 17 having a charge value between ?1 and ?3 or a polyatomic ion having a charge between ?1 and ?3.

Abstract: An electrolyte composition for use in an electrolytic cell and an electrolytic cell that includes the same. The electrolytic cell includes a chemical component having the general formula: [ H x ? O ( x - 1 ) 2 ] ? Z y I wherein x is an odd integer ?3; y is an integer between 1 and 20; and Z is one of a monoatomic ion from Groups 14 through 17 having a charge value between ?1 and ?3 or a polyatomic ion having a charge between ?1 and ?3. The electrolytic composition also includes between 1 and 300 ppm ionic salts selected from the group consisting of alkali metals salts and alkali earth metal salts and mixtures thereof; and water. The battery electrolyte composition has a specific gravity between 1.07 and 1.

Abstract: A method of making an alkaline hydronium composition and composition of matter having the following chemical structure: [HxOx-y]mZn where x is an integer greater than 3; y is and integer less than x; and wherein the charge value associated with the molecular component is at least ?1

Abstract: Method and composition for treating or preventing a respiratory illness. The method includes administering at least one dose of a pharmaceutically acceptable fluid having a pH less than 3.0 into contact with at least one region of the respiratory tract present in a patient in need thereof. Respiratory illness that can be treated include COVID-19.

Abstract: A method of making an alkaline hydronium composition and composition of matter having the following chemical structure: [HxOx-y]mZn where x is an integer greater than 3; y is and integer less than x; and wherein the charge value associated with the molecular component is at least ?1.

Abstract: An electrolyte composition for use in an electrolytic cell and an electrolytic cell that includes the same. The electrolytic cell includes a chemical component having the general formula: [ H x ? O ( x - 1 ) 2 ] ? Z y I wherein x is an odd integer ?3; y is an integer between 1 and 20; and Z is one of a monoatomic ion from Groups 14 through 17 having a charge value between ?1 and ?3 or a polyatomic ion having a charge between ?1 and ?3. The electrolytic composition also includes between 1 and 300 ppm ionic salts selected from the group consisting of alkali metals salts and alkali earth metal salts and mixtures thereof; and water. The battery electrolyte composition has a specific gravity between 1.07 and 1.4.

Abstract: Method and composition for treating or preventing a respiratory illness. The method includes administering at least one dose of a pharmaceutically acceptable fluid having a pH less than 3.0 into contact with at least one region of the respiratory tract present in a patient in need thereof. Respiratory illness that can be treated include COVID-19.